Author Question: Ms. Youmans has a class of 24 sixth graders12 girls and 12 boys. Given what we know about gender ... (Read 87 times)

Tirant22

  • Hero Member
  • *****
  • Posts: 532
Ms. Youmans has a class of 24 sixth graders12 girls and 12 boys. Given what we know about gender differences in verbal ability and visual-spatial ability, which one of the following is Ms. Youmans justified in concluding about her students?
 
  a. Her highest reading group will have almost all girls, and her lowest reading group will have mostly boys.
  b. All of the boys should do better than all of the girls on a test of visual-spatial ability.
  c. About 80 of the boys should do better than 80 of the girls on a test of visual-spatial ability.
  d. Ms. Youmans probably won't notice differences in the average abilities of boys and girls.

Question 2

A test that has the same meaning for members of all cultures.
 
  a. culture-free test
  b. culture-fair test
  c. cultural relevance
  d. criterion-referenced



dudman123

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

d

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

Although not all of the following muscle groups are commonly used, intramuscular injections may be given into the abdominals, biceps, calves, deltoids, gluteals, laterals, pectorals, quadriceps, trapezoids, and triceps.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library